Can a smarter breathing machine protect premature brains?

NCT ID NCT06786039

First seen Aug 05, 2026 · Last updated Aug 06, 2026 · Updated 1 time

Summary

This study looks at whether a special breathing support called NIV-NAVA, which works with a baby's own breathing efforts, can improve outcomes for very premature infants. Researchers will follow about 80 babies born between 27 and 31 weeks of pregnancy who need breathing help soon after birth. They will track how often the support fails, lung problems, and long-term brain development to see if this approach offers benefits.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Non-invasive neurally adjusted ventilatory assist (NIV-NAVA), a breathing support method that synchronizes with the infant's own breathing signals
What this could lead to
If this approach works well, it could lead to better breathing support strategies for very preterm infants, potentially reducing complications and improving long-term development.
What could go wrong
This is an observational study, so it cannot prove cause and effect. Results may be influenced by other factors, and the approach may not work for all infants.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PRETERM INFANT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Premature Birth

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Korea University Anam Hospital, NICU

    RECRUITING

    Seoul, Seoul, 02841, South Korea

  • Seoul National Bundang Hospital NICU

    NOT_YET_RECRUITING

    Seongnam-si, Gyeonggi-do, 13620, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.